Journal
/
/
Síntesis y caracterización de un profármaco Aspirina-fumarato que inhibe la actividad de NFkB y de la mama células madre del cáncer
Journal JoVE
Recherche en cancérologie
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Recherche en cancérologie
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
DOI:

13:38 min

January 18, 2017

, , , ,

Chapitres

  • 00:05Titre
  • 01:13Synthesis of Aspirin-fumarate Prodrug, GTCpFE
  • 06:10Inhibiting the NFκB Activity with GTCpFE in Breast Cancer Cells
  • 07:22Inhibiting Breast Cancer Stem Cells with GTCpFE In Vitro
  • 10:11Results: GTCpFE Inhibits the NFκB Pathway, Mammosphere Formation, and the CD44+CD24 Immunophenotype in Breast Cancer Cells
  • 11:49Conclusion

Summary

Traduction automatique

This procedure will demonstrate how we synthesized and characterized the anti-NFκB and anti-cancer stem cell activity of an aspirin-fumarate prodrug.

Vidéos Connexes

Read Article